SCHEMBL3408927

SCHEMBL3408927

CN(C)c1ccccc1C(=O)N1CCN(c2cccnn2)CC1

nearest known ligand 0.58

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
SLC6A7 Q99884 1/20 0.58
ALDH1A1 P00352 6/20 0.51
NAMPT P43490 1/20 0.49
HSD17B10 Q99714 4/20 0.48
KDM4E B2RXH2 3/20 0.48
HPGD P15428 2/20 0.48
CYP2C9 P11712 1/20 0.48
CYP2C19 P33261 1/20 0.48
MEN1 O00255 1/20 0.48
KMT2A Q03164 1/20 0.48
TRPV1 Q8NER1 2/20 0.47
GBA1 P04062 1/20 0.47
TSHR P16473 3/20 0.46
LMNA P02545 2/20 0.46
GAA P10253 1/20 0.46
MAPT P10636 1/20 0.44
SMN1; SMN2 Q16637 2/20 0.43
POLB P06746 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5318255 0.89 GAA (0.53) SLC6A7ALDH1A1NAMPTHSD17B10KDM4E
SCHEMBL3429910 0.81 SLC6A7 (0.62) SLC6A7ALDH1A1NAMPTHSD17B10KDM4E
SCHEMBL936620 0.81 SCD (0.51) GBA1
SCHEMBL3430705 0.80 SLC6A7 (0.57) SLC6A7ALDH1A1NAMPTHSD17B10KDM4E
SCHEMBL2007249 0.78 SCD (0.61) SLC6A7GBA1
SCHEMBL3432771 0.77 SLC6A7 (0.57) SLC6A7ALDH1A1NAMPTHSD17B10KDM4E
SCHEMBL13779950 0.76 L3MBTL1 (0.60) ALDH1A1KDM4EHPGDMEN1KMT2A
SCHEMBL27702525 0.75 SLC6A7 (0.63) SLC6A7ALDH1A1NAMPTHSD17B10KDM4E
SCHEMBL3432265 0.75 SLC6A7 (0.55) SLC6A7ALDH1A1NAMPTHSD17B10KDM4E
SCHEMBL3430961 0.75 GAA (0.73) ALDH1A1HSD17B10KDM4EHPGDCYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2257291-A2 PYRIDAZINE DERIVATIVES AND THEIR USE AS THERAPEUTIC AGENTS IN THE TREATMENT OF SKIN DISORDERS Xenon Pharmaceuticals Inc. (CA) 2010-12-08 EP disclosed
WO-2009106991-A2 PYRIDAZINE DERIVATIVES AND THEIR USE AS THERAPEUTIC AGENTS XENON PHARMACEUTICALS INC. (CA) 2009-09-03 WO disclosed